B. Oliveri et al., VITAMIN-D PROPHYLAXIS IN CHILDREN WITH A SINGLE-DOSE OF 150000-IU OF VITAMIN-D, European journal of clinical nutrition, 50(12), 1996, pp. 807-810
Objective: To determine the efficacy of a single oral dose of 150000 I
U of vitamin D-2 at the beginning of autumn for preventing winter vita
min D deficiency in children in Ushuaia (55 degrees S). Design: The st
udy was prospective. Subjects: 79 children clinically healthy with 8.6
+/- 1.4 y of age (X +/- s.d.). Interventions: Fasting serum venous sa
mples and 2 h urine samples were obtained immediately before and 6 w a
nd 5 mon after the vitamin D dose. Parents informed consent was obtain
ed previous to the study. In a subgroup of 30 children serum levels of
calcium (sCa), phosphorus (sP), total alkaline phosphatase (TAP), 25
hydroxyvitamin D (25 OHD), parathyroid hormone (PTH) and the urine cal
cium/creatinine ratio in a 2 h urine sample (UCa/UCreat) were measured
. In the whole group sCa and the ratio uCa/ucreat were measured. Resul
ts: After 150000 IU of vitamin D-2 administration, serum 25 OHD levels
at the end of winter (17.0 +/- 9.4 ng/ml) were similar to those at th
e beginning of autumn (18.7 +/- 10.7 ng/ml), but significantly higher
from those obtained in a previous study without vitamin D (9.8 +/- 3.8
ng/ml, P < 0.001). PTH levels were higher at the end of winter (P < 0
.02), but this augmentation was lower than the increment observed with
out vitamin D. Plasma calcium levels and the urine calcium/creatinine
ratio were lower at 5 months after vitamin D-2 dose (P < 0.02 and P <
0.05 respectively). In the total group the serum calcium was lower aft
er the fifth month (P < 0.05). The Uca/Ucreat ratio was lower at 6 w a
nd 5 mon (P < 0.05 and P < 0.001). Conclusion: A single dose of 150000
IU of vitamin D maintained appropriate levels of 25 OHD without induc
ing hypercalcemia nor hypercalciuria, but a winter increment of PTH (s
maller than in the group without vitamin D) was not inhibited. Sponsor
ship: Nestle Nutrition Research Grant Programme.